MindMap Gallery AstraZeneca Organizational Chart

AstraZeneca Organizational Chart

This organizational chart reveals the intricate structure of AstraZeneca, highlighting synergy between Research & Development and Commercial Operations. Board of Directors guided by CEO, who oversees executive roles: CFO (finance, capital allocation), CHRO (talent, culture), CIO/CDO (digital, data). Divisions: Finance (planning, reporting), Legal (compliance, IP), Human Resources (training, recruiting), Digital Innovations (AI, data analytics, digital health). R&D organization, led by Chief R&D Officer, encompasses: Discovery Sciences: biology, chemistry, genetics, biomarkers. Preclinical Development: pharmacology, toxicology, ADME, formulation. Clinical Development: phase 1–3 trials, biostatistics, data management. Regulatory Affairs: FDA, EMA filings, post-market commitments. Medical Affairs: scientific communication, real-world evidence. Commercial Operations: Global Commercial (marketing, sales, market access), Therapeutic Areas (oncology, cardiovascular, respiratory, rare diseases). Patient engagement: patient support (co-pay, nurse educators), disease awareness. Shared services: Supply Chain (manufacturing, logistics), Quality (cGMP, compliance), Corporate Communications (investor, public), Sustainability (ESG, carbon reduction). This framework drives healthcare forward through innovation, efficiency, and patient-centricity.

Edited at 2026-03-25 15:01:50
PlotWizard
PlotWizard

AstraZeneca Organizational Chart

PlotWizard
PlotWizard
  • Recommended to you
  • Outline